Clinical trial
Efficacy and Safety of S-ketamine Hydrochloride Injection in Elderly Patients Undergoing Elective Non-cardiac Surgery: a Multicenter, Randomized, Placebo Controlled Clinical Trials(ESSENCE)
NCT07063108 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of S-ketamine Hydrochloride Injection in Elderly Patients Undergoing Elective Non-cardiac Surgery: a Multicenter, Randomized, Placebo Controlled Clinical Trials(ESSENCE)
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- December 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 276 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.